Literature DB >> 10940218

Review: amyloidogenesis-unquestioned answers and unanswered questions.

R Kisilevsky1.   

Abstract

Current assumptions and conclusions in several active areas of amyloid research are examined to see how consistent the data from chosen in vitro and in vivo model systems are with clinical and anatomic observations. These areas include the assembly of amyloid-like fibrils in vitro, the nucleation phenomenon, amyloid fibril structure in vivo and in vitro, common structural components of the amyloids, and the regression of tissue amyloid and proteolysis of amyloid proteins. Divergences and congruencies are highlighted, which in turn suggests caution in the interpretation of present data, greater collaboration and communication among investigators, and, additional areas and techniques for investigation. Copyright 2000 Academic Press.

Mesh:

Substances:

Year:  2000        PMID: 10940218     DOI: 10.1006/jsbi.2000.4222

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  27 in total

1.  Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL.

Authors:  David Zanuy; Buyong Ma; Ruth Nussinov
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

2.  Imaging linear birefringence and dichroism in cerebral amyloid pathologies.

Authors:  Lee-Way Jin; Kacey A Claborn; Miki Kurimoto; Morten A Geday; Izumi Maezawa; Faranak Sohraby; Marcus Estrada; Werner Kaminksy; Bart Kahr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

3.  Freezing of a fish antifreeze protein results in amyloid fibril formation.

Authors:  Steffen P Graether; Carolyn M Slupsky; Brian D Sykes
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

4.  Mutagenic exploration of the cross-seeding and fibrillation propensity of Alzheimer's beta-amyloid peptide variants.

Authors:  Alexander Peim; Peter Hortschansky; Tony Christopeit; Volker Schroeckh; Walter Richter; Marcus Fändrich
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

Review 5.  Amyloid accomplices and enforcers.

Authors:  Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

6.  In vitro polymerization of a functional Escherichia coli amyloid protein.

Authors:  Xuan Wang; Daniel R Smith; Jonathan W Jones; Matthew R Chapman
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

7.  Protein particulates: another generic form of protein aggregation?

Authors:  Mark R H Krebs; Glyn L Devlin; A M Donald
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

8.  Do chaperonins boost protein yields by accelerating folding or preventing aggregation?

Authors:  A I Jewett; J-E Shea
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

9.  Development and evaluation of agents for targeting visceral amyloid.

Authors:  Jonathan S Wall; Alan Solomon; Stephen J Kennel
Journal:  Tijdschr Nucl Geneeskd       Date:  2011-12

10.  Clinical profile of patients having pulmonary tuberculosis and renal amyloidosis.

Authors:  Ramakant Dixit; Rakesh Gupta; Lokendra Dave; Nishi Prasad; Sidharth Sharma
Journal:  Lung India       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.